HYDROCORTISONE

HYDROCORTISONE was reported 90082 times

HYDROCORTISONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 191 0.6304
1 HUMAN BOCAVIRUS INFECTION 114 0.6032
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 980 0.4893
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 319 0.4775
4 LUPUS VULGARIS 584 0.4635
5 C-REACTIVE PROTEIN 426 0.4595
6 SWOLLEN JOINT COUNT INCREASED 1431 0.4483
7 RHEUMATIC FEVER 1955 0.4381
8 SLEEP DISORDER THERAPY 85 0.4293
9 GRIP STRENGTH 96 0.4192
10 FACET JOINT SYNDROME 1284 0.3940
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 795 0.3833
12 TOPICAL STEROID WITHDRAWAL REACTION 149 0.3830
13 SWOLLEN JOINT COUNT 87 0.3480
14 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2485 0.3465
15 DUODENAL ULCER PERFORATION 2552 0.3428
16 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 192 0.3422
17 DISLOCATION OF VERTEBRA 763 0.3342
18 RHEUMATOID FACTOR POSITIVE 1864 0.3224
19 X-RAY ABNORMAL 573 0.3201
20 CYSTITIS BACTERIAL 97 0.2870
21 CRANIOPHARYNGIOMA 93 0.2801
22 NOROVIRUS TEST POSITIVE 90 0.2769
23 ANALGESIC THERAPY 88 0.2741
24 APPENDICOLITH 105 0.2713
25 ADRENOCORTICAL INSUFFICIENCY ACUTE 506 0.2591
26 RETINITIS 447 0.2585
27 STEROID DEPENDENCE 226 0.2574
28 STEROID WITHDRAWAL SYNDROME 255 0.2495
29 HELICOBACTER INFECTION 2539 0.2468
30 PEMPHIGUS 2856 0.2282
31 PERIPHERAL VENOUS DISEASE 920 0.2250
32 MUSCLE INJURY 1861 0.2244
33 HAND DEFORMITY 2805 0.2136
34 MYCOBACTERIUM CHELONAE INFECTION 157 0.2124
35 C-REACTIVE PROTEIN ABNORMAL 1349 0.2101
36 FOLLICULITIS 2161 0.2059
37 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1330 0.2046
38 CATARRH 176 0.1947
39 SECONDARY IMMUNODEFICIENCY 230 0.1893
40 SERONEGATIVE ARTHRITIS 208 0.1815
41 PORPHYRIA ACUTE 256 0.1784
42 ADRENAL SUPPRESSION 150 0.1779
43 PERICARDITIS 2833 0.1685
44 SYNOVITIS 3035 0.1682
45 BREAST CANCER STAGE III 1007 0.1553
46 OVERLAP SYNDROME 106 0.1514
47 LIP DRY 1293 0.1422
48 FEMALE GENITAL TRACT FISTULA 236 0.1381
49 BONE EROSION 466 0.1316
50 GLOSSODYNIA 2942 0.1313
51 HYPOFIBRINOGENAEMIA 128 0.1290
52 ONYCHOMADESIS 540 0.1285
53 JOINT RANGE OF MOTION DECREASED 1723 0.1283
54 GRIP STRENGTH DECREASED 1122 0.1274
55 DRUG TOLERANCE DECREASED 353 0.1256
56 HYPERCHOLESTEROLAEMIA 1213 0.1255
57 LIVE BIRTH 1004 0.1199
58 PSEUDOMONAL SEPSIS 200 0.1141
59 WOUND INFECTION 1247 0.1138
60 WOUND 3158 0.1129
61 ONYCHOMYCOSIS 487 0.1109
62 BURSITIS 1330 0.1095
63 AUTOIMMUNE DISORDER 1020 0.1045
64 IRRITABLE BOWEL SYNDROME 2196 0.1023
65 PARAINFLUENZAE VIRUS INFECTION 155 0.1018
66 FEBRILE BONE MARROW APLASIA 415 0.0976
67 BURNS SECOND DEGREE 170 0.0968
68 RADICULOPATHY 253 0.0959
69 BLEPHAROSPASM 598 0.0949
70 ADRENAL INSUFFICIENCY 1143 0.0941
71 SYSTEMIC LUPUS ERYTHEMATOSUS 3295 0.0927
72 FIBROMYALGIA 2236 0.0919
73 HUMAN HERPESVIRUS 6 INFECTION 170 0.0899
74 DEATH NEONATAL 124 0.0891
75 SECONDARY ADRENOCORTICAL INSUFFICIENCY 134 0.0887
76 PROCTITIS 247 0.0881
77 CORTISOL DECREASED 96 0.0840
78 ENTEROBACTER INFECTION 135 0.0803
79 BODY TEMPERATURE FLUCTUATION 161 0.0772
80 CHRONIC SINUSITIS 278 0.0740
81 MATERNAL EXPOSURE TIMING UNSPECIFIED 278 0.0739
82 SCIATICA 1171 0.0734
83 CONTRAINDICATED PRODUCT ADMINISTERED 2214 0.0731
84 TYPE 2 DIABETES MELLITUS 2457 0.0729
85 IMPAIRED HEALING 2383 0.0725
86 DRUG LEVEL BELOW THERAPEUTIC 395 0.0715
87 LIVER INJURY 1745 0.0710
88 DIABETES INSIPIDUS 168 0.0697
89 NAIL DISORDER 608 0.0694
90 PITUITARY TUMOUR BENIGN 113 0.0692
91 FINGER DEFORMITY 331 0.0683
92 VIRAEMIA 94 0.0678
93 EXOSTOSIS 619 0.0677
94 INFUSION RELATED REACTION 4483 0.0676
95 FAECAL CALPROTECTIN INCREASED 212 0.0669
96 ADRENAL DISORDER 127 0.0661
97 WALKING AID USER 434 0.0658
98 INSULIN-LIKE GROWTH FACTOR INCREASED 93 0.0652
99 PUSTULAR PSORIASIS 224 0.0652
100 HYPOPITUITARISM 109 0.0626
101 OBESITY 998 0.0626
102 PRODUCT LABEL CONFUSION 359 0.0615
103 PULMONARY FIBROSIS 1181 0.0615
104 PSORIATIC ARTHROPATHY 2446 0.0602
105 LOWER LIMB FRACTURE 1106 0.0575
106 SKIN WEEPING 204 0.0571
107 RED BLOOD CELL SEDIMENTATION RATE INCREASED 628 0.0567
108 LUPUS-LIKE SYNDROME 508 0.0560
109 ARTHROPATHY 3052 0.0549
110 CYTOMEGALOVIRUS CHORIORETINITIS 107 0.0548
111 ANAL FISSURE 294 0.0548
112 PRESCRIBED OVERDOSE 1051 0.0543
113 LOWER RESPIRATORY TRACT INFECTION 2445 0.0537
114 BRONCHIECTASIS 360 0.0534
115 BLOOD PRESSURE FLUCTUATION 1270 0.0529
116 HYPOPNOEA 183 0.0527
117 ULCER HAEMORRHAGE 355 0.0524
118 EYE INJURY 159 0.0523
119 HYPERPHOSPHATAEMIA 112 0.0520
120 RHINOVIRUS INFECTION 202 0.0518
121 BLOOD CHOLESTEROL INCREASED 2395 0.0513
122 RASH VESICULAR 241 0.0498
123 GAIT INABILITY 1652 0.0494
124 FOOT DEFORMITY 547 0.0493
125 HYPOPHYSITIS 99 0.0492
126 PNEUMATOSIS INTESTINALIS 139 0.0487
127 INTENTIONAL PRODUCT USE ISSUE 4267 0.0487
128 BREAST CANCER STAGE II 402 0.0483
129 BLOOD PRESSURE DIASTOLIC DECREASED 356 0.0482
130 SPONDYLITIS 174 0.0478
131 HIP ARTHROPLASTY 729 0.0476
132 JOINT DISLOCATION 501 0.0473
133 BLISTER 2656 0.0472
134 NORMAL NEWBORN 250 0.0459
135 HEPATIC ENZYME INCREASED 3135 0.0459
136 THERAPEUTIC PRODUCT EFFECT DECREASED 2032 0.0453
137 BACK INJURY 491 0.0451
138 DISCOMFORT 2730 0.0447
139 INFUSION SITE REACTION 133 0.0445
140 OSTEOARTHRITIS 1863 0.0439
141 CUSHINGOID 141 0.0439
142 PRESCRIBED UNDERDOSE 876 0.0439
143 COELIAC DISEASE 430 0.0438
144 APLASTIC ANAEMIA 226 0.0432
145 DRUG LEVEL ABOVE THERAPEUTIC 198 0.0432
146 BLOOD PHOSPHORUS INCREASED 118 0.0432
147 FREQUENT BOWEL MOVEMENTS 1142 0.0422
148 CONGENITAL ANOMALY 327 0.0422
149 C-REACTIVE PROTEIN INCREASED 1530 0.0420
150 ALCOHOL POISONING 111 0.0414
151 WHEEZING 2438 0.0411
152 STOMATITIS 2482 0.0409
153 BLOOD PRESSURE DIASTOLIC INCREASED 185 0.0400
154 NIGHT SWEATS 1284 0.0398
155 POOR VENOUS ACCESS 409 0.0395
156 SWELLING 3636 0.0388
157 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 651 0.0379
158 BODY TEMPERATURE DECREASED 368 0.0373
159 DRUG SPECIFIC ANTIBODY PRESENT 243 0.0373
160 INFLAMMATION 1899 0.0368
161 BRONCHOPULMONARY ASPERGILLOSIS 279 0.0359
162 MOBILITY DECREASED 2560 0.0356
163 ERYTHEMA NODOSUM 125 0.0356
164 IRON DEFICIENCY 160 0.0355
165 DRUG LEVEL DECREASED 362 0.0355
166 MUCOUS STOOLS 175 0.0353
167 DRUG INTOLERANCE 3408 0.0352
168 COLITIS ULCERATIVE 1574 0.0352
169 APHTHOUS ULCER 270 0.0348
170 SERUM SICKNESS 97 0.0348
171 RHEUMATOID ARTHRITIS 3928 0.0346
172 OEDEMA 1875 0.0345
173 KNEE ARTHROPLASTY 727 0.0345
174 ASPERGILLUS INFECTION 226 0.0344
175 CLOSTRIDIUM DIFFICILE COLITIS 363 0.0342
176 TASTE DISORDER 687 0.0338
177 LEUKOENCEPHALOPATHY 124 0.0333
178 BACTERIAL INFECTION 616 0.0330
179 RHINITIS 263 0.0326
180 MATERNAL EXPOSURE DURING PREGNANCY 2881 0.0323
181 JOINT SWELLING 3900 0.0323
182 INJURY 2271 0.0323
183 ROAD TRAFFIC ACCIDENT 1347 0.0322
184 ENTERITIS 206 0.0322
185 HYPERTRIGLYCERIDAEMIA 188 0.0321
186 MUSCULOSKELETAL STIFFNESS 2813 0.0321
187 SLEEP DISORDER 2230 0.0316
188 LIVER FUNCTION TEST INCREASED 678 0.0315
189 ILL-DEFINED DISORDER 1905 0.0313
190 ORAL CANDIDIASIS 407 0.0309
191 BLOOD PRESSURE SYSTOLIC INCREASED 598 0.0306
192 GINGIVAL PAIN 244 0.0306
193 MYOSITIS 274 0.0305
194 LUNG DISORDER 1494 0.0305
195 EPILEPSY 918 0.0300
196 OESOPHAGEAL CANDIDIASIS 119 0.0298
197 KLEBSIELLA INFECTION 151 0.0298
198 SPINAL FUSION SURGERY 121 0.0298
199 GENERAL PHYSICAL HEALTH DETERIORATION 3448 0.0298
200 SKIN ATROPHY 169 0.0293
201 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 146 0.0288
202 NEOPLASM RECURRENCE 97 0.0286
203 HYPOPHOSPHATAEMIA 211 0.0285
204 CYTOMEGALOVIRUS VIRAEMIA 127 0.0285
205 HEPATIC CIRRHOSIS 534 0.0284
206 WEIGHT FLUCTUATION 297 0.0284
207 DELIRIUM 978 0.0282
208 ANAL FISTULA 149 0.0279
209 TREATMENT FAILURE 2311 0.0279
210 HEART RATE DECREASED 974 0.0277
211 MUSCULOSKELETAL PAIN 1444 0.0275
212 LIVER DISORDER 1214 0.0273
213 STAPHYLOCOCCAL SEPSIS 135 0.0273
214 EAR INFECTION 717 0.0269
215 DRUG-INDUCED LIVER INJURY 840 0.0267
216 PAROSMIA 202 0.0267
217 VENOUS THROMBOSIS 105 0.0267
218 RESPIRATORY RATE INCREASED 233 0.0262
219 CARDIAC MURMUR 227 0.0262
220 VAGINAL DISCHARGE 263 0.0260
221 GASTROINTESTINAL DISORDER 2320 0.0259
222 HYPERNATRAEMIA 129 0.0259
223 FISTULA 290 0.0258
224 SINUSITIS 2634 0.0257
225 RECTAL HAEMORRHAGE 1101 0.0256
226 JOINT STIFFNESS 672 0.0256
227 ENTEROCOCCAL INFECTION 123 0.0254
228 THERAPY NON-RESPONDER 1140 0.0253
229 GENERAL SYMPTOM 190 0.0253
230 INFUSION SITE EXTRAVASATION 156 0.0250
231 EAR PAIN 485 0.0249
232 EXPOSURE DURING PREGNANCY 1534 0.0247
233 DRY MOUTH 2002 0.0246
234 PROCTALGIA 158 0.0245
235 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 416 0.0245
236 ANAL ABSCESS 131 0.0243
237 MUCOSAL INFLAMMATION 634 0.0242
238 ADVERSE REACTION 320 0.0241
239 CONTUSION 2318 0.0241
240 BLOOD URIC ACID INCREASED 139 0.0240
241 HEART RATE IRREGULAR 540 0.0239
242 OSTEOPOROSIS 972 0.0236
243 ABDOMINAL DISCOMFORT 3959 0.0236
244 POLYARTHRITIS 124 0.0235
245 IMPAIRED QUALITY OF LIFE 337 0.0234
246 CONDITION AGGRAVATED 7110 0.0234
247 PREGNANCY 467 0.0233
248 RALES 135 0.0232
249 SUSPECTED OFF LABEL USE 105 0.0232
250 FEBRILE NEUTROPENIA 1531 0.0231
251 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1104 0.0230
252 NEUTROPENIC SEPSIS 163 0.0228
253 DEFAECATION URGENCY 158 0.0225
254 WOUND SECRETION 88 0.0224
255 HAEMATOCHEZIA 1229 0.0222
256 DYSPEPSIA 2179 0.0221
257 RESPIRATORY DISORDER 659 0.0220
258 GRAFT VERSUS HOST DISEASE 157 0.0218
259 SPUTUM DISCOLOURED 207 0.0218
260 SKIN PLAQUE 184 0.0218
261 INFLAMMATORY MARKER INCREASED 108 0.0218
262 DISABILITY 430 0.0217
263 BODY TEMPERATURE INCREASED 443 0.0217
264 HYPERSENSITIVITY 4030 0.0217
265 MIGRAINE 2068 0.0216
266 PARAESTHESIA ORAL 311 0.0215
267 HERPES SIMPLEX 140 0.0215
268 PSEUDOMONAS INFECTION 184 0.0214
269 RED CELL DISTRIBUTION WIDTH INCREASED 89 0.0214
270 APPENDICITIS 200 0.0214
271 INFECTION 3092 0.0213
272 VAGINAL INFECTION 100 0.0212
273 BREATH SOUNDS ABNORMAL 104 0.0211
274 MULTIPLE ORGAN DYSFUNCTION SYNDROME 591 0.0208
275 SEPTIC SHOCK 900 0.0207
276 HYPOAESTHESIA 3093 0.0206
277 NASOPHARYNGITIS 3798 0.0206
278 COLITIS 781 0.0206
279 PERIPHERAL SWELLING 3168 0.0205
280 CANDIDA INFECTION 346 0.0205
281 ARTHRITIS INFECTIVE 95 0.0205
282 UVEITIS 277 0.0204
283 ALOPECIA 4008 0.0204
284 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1443 0.0203
285 ARTHRITIS 1577 0.0200
286 ABSCESS 319 0.0200
287 DRUG TOLERANCE 101 0.0199
288 FAECES SOFT 145 0.0199
289 GASTROINTESTINAL INFLAMMATION 156 0.0199
290 WEIGHT INCREASED 4450 0.0199
291 BACK DISORDER 323 0.0198
292 HYPERTENSION 4174 0.0197
293 MYASTHENIA GRAVIS 159 0.0197
294 URTICARIA 3289 0.0196
295 NEURALGIA 477 0.0196
296 SKIN INFECTION 219 0.0195
297 HYPERTRANSAMINASAEMIA 135 0.0194
298 BENIGN PROSTATIC HYPERPLASIA 100 0.0193
299 CONFUSIONAL STATE 3124 0.0193
300 SENSITIVITY TO WEATHER CHANGE 101 0.0192
301 MUSCLE SPASTICITY 234 0.0190
302 HYPOALBUMINAEMIA 148 0.0190
303 HEPATITIS 486 0.0190
304 SKIN ABRASION 89 0.0188
305 PAPULE 131 0.0186
306 NEPHROGENIC ANAEMIA 86 0.0185
307 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 176 0.0184
308 THERAPEUTIC RESPONSE SHORTENED 609 0.0183
309 BACTERAEMIA 217 0.0183
310 CLOSTRIDIUM DIFFICILE INFECTION 396 0.0181
311 VIRAL INFECTION 602 0.0181
312 TENDERNESS 185 0.0177
313 ORAL DISORDER 129 0.0176
314 MACULAR DEGENERATION 210 0.0176
315 SKIN WARM 102 0.0175
316 ECZEMA 917 0.0175
317 GASTROENTERITIS 255 0.0175
318 ASTHMA 1974 0.0174
319 PNEUMOCYSTIS JIROVECII PNEUMONIA 175 0.0174
320 VENOOCCLUSIVE LIVER DISEASE 86 0.0174
321 CARDIOGENIC SHOCK 249 0.0173
322 TOXIC EPIDERMAL NECROLYSIS 263 0.0173
323 ARTHRALGIA 7080 0.0170
324 UPPER RESPIRATORY TRACT INFECTION 780 0.0169
325 NECK PAIN 939 0.0168
326 ENCEPHALITIS 116 0.0168
327 HYPERBILIRUBINAEMIA 173 0.0167
328 DIARRHOEA HAEMORRHAGIC 156 0.0167
329 JOINT EFFUSION 115 0.0167
330 SPINAL OSTEOARTHRITIS 146 0.0166
331 VENTRICULAR FIBRILLATION 184 0.0165
332 ATELECTASIS 158 0.0163
333 OBSTRUCTIVE AIRWAYS DISORDER 181 0.0163
334 PYREXIA 5606 0.0162
335 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2912 0.0161
336 INTRACRANIAL PRESSURE INCREASED 90 0.0161
337 INFUSION SITE SWELLING 101 0.0160
338 SECRETION DISCHARGE 201 0.0160
339 HYDROCEPHALUS 87 0.0160
340 AMNESIA 1038 0.0159
341 PRODUCT USE ISSUE 2995 0.0159
342 ONYCHOCLASIS 109 0.0158
343 MEDICATION ERROR 880 0.0158
344 ORAL HERPES 309 0.0158
345 TOOTH INFECTION 208 0.0158
346 TROPONIN INCREASED 119 0.0156
347 STREPTOCOCCAL INFECTION 87 0.0156
348 HAEMORRHOIDS 303 0.0155
349 HYPERLIPIDAEMIA 185 0.0155
350 ANAL INCONTINENCE 139 0.0154
351 TUMOUR LYSIS SYNDROME 135 0.0153
352 HYPONATRAEMIA 861 0.0153
353 HYPOKALAEMIA 702 0.0152
354 PRODUCTIVE COUGH 726 0.0152
355 BLOOD PRESSURE INCREASED 2322 0.0152
356 RASH 6600 0.0151
357 SKIN LACERATION 164 0.0151
358 DRUG LEVEL INCREASED 249 0.0150
359 INFUSION SITE PAIN 193 0.0150
360 MUSCULAR WEAKNESS 1691 0.0149
361 SPINAL PAIN 174 0.0148
362 OXYGEN SATURATION DECREASED 834 0.0148
363 IMMUNOSUPPRESSION 130 0.0147
364 JOINT INJURY 314 0.0147
365 IMMUNODEFICIENCY 218 0.0146
366 SLEEP APNOEA SYNDROME 279 0.0146
367 GASTROOESOPHAGEAL REFLUX DISEASE 1174 0.0146
368 FEELING HOT 892 0.0145
369 MOUTH ULCERATION 306 0.0145
370 ABDOMINAL PAIN 3372 0.0145
371 ARTERIOSCLEROSIS CORONARY ARTERY 96 0.0145
372 ABDOMINAL PAIN UPPER 2943 0.0143
373 SKIN LESION 391 0.0142
374 WEIGHT DECREASED 3977 0.0142
375 TACHYCARDIA 1260 0.0142
376 GASTROINTESTINAL INFECTION 127 0.0142
377 BRONCHITIS 1048 0.0141
378 SEPSIS 1576 0.0141
379 IMPAIRED WORK ABILITY 300 0.0140
380 TUBULOINTERSTITIAL NEPHRITIS 263 0.0140
381 CYST 174 0.0140
382 SCRATCH 147 0.0139
383 CONCOMITANT DISEASE AGGRAVATED 86 0.0139
384 OFF LABEL USE 12194 0.0139
385 INTERVERTEBRAL DISC PROTRUSION 303 0.0138
386 OSTEOPENIA 210 0.0138
387 OEDEMA PERIPHERAL 1684 0.0138
388 TENDON DISORDER 90 0.0138
389 ACUTE RESPIRATORY DISTRESS SYNDROME 244 0.0138
390 MENISCUS INJURY 84 0.0136
391 ABDOMINAL DISTENSION 1421 0.0136
392 RASH PRURITIC 737 0.0136
393 PARAESTHESIA 2138 0.0136
394 PRURITUS 5221 0.0136
395 APPETITE DISORDER 90 0.0136
396 DECREASED APPETITE 3130 0.0135
397 FEELING COLD 374 0.0134
398 ABNORMAL FAECES 110 0.0134
399 OROPHARYNGEAL PAIN 1240 0.0134
400 ULCER 213 0.0134
401 CHEST PAIN 2478 0.0134
402 END STAGE RENAL DISEASE 244 0.0134
403 DERMATITIS 280 0.0133
404 PAIN IN EXTREMITY 3930 0.0133
405 LIPASE INCREASED 102 0.0133
406 PRODUCT USE IN UNAPPROVED INDICATION 3295 0.0133
407 GAIT DISTURBANCE 2543 0.0133
408 INFUSION SITE ERYTHEMA 112 0.0133
409 HYPERGLYCAEMIA 484 0.0133
410 BLOOD CALCIUM INCREASED 116 0.0132
411 TOOTH ABSCESS 134 0.0131
412 CYSTITIS 419 0.0131
413 RESPIRATORY DISTRESS 362 0.0131
414 SKIN FISSURES 256 0.0131
415 BLOOD IRON DECREASED 155 0.0130
416 MEMORY IMPAIRMENT 1794 0.0130
417 HYPERTHYROIDISM 189 0.0130
418 ORAL PAIN 291 0.0130
419 GOUT 232 0.0129
420 POST PROCEDURAL INFECTION 105 0.0129
421 FLANK PAIN 121 0.0129
422 FUNGAL INFECTION 427 0.0128
423 PNEUMONIA 4146 0.0128
424 ASPIRATION 140 0.0128
425 ACIDOSIS 97 0.0127
426 LUNG INFILTRATION 112 0.0127
427 NERVE COMPRESSION 117 0.0127
428 BLOOD TEST ABNORMAL 178 0.0127
429 PHARYNGITIS STREPTOCOCCAL 137 0.0126
430 RHINORRHOEA 818 0.0126
431 VITAMIN D DECREASED 108 0.0126
432 PRODUCT ADMINISTRATION INTERRUPTED 99 0.0126
433 PALLOR 343 0.0126
434 MALNUTRITION 141 0.0126
435 HAEMODYNAMIC INSTABILITY 96 0.0126
436 LUNG INFECTION 195 0.0125
437 RASH ERYTHEMATOUS 599 0.0125
438 STAPHYLOCOCCAL INFECTION 412 0.0125
439 SKIN HYPERPIGMENTATION 107 0.0124
440 SKIN SWELLING 108 0.0124
441 SKIN DISORDER 415 0.0124
442 MICTURITION URGENCY 142 0.0124
443 ESCHERICHIA INFECTION 102 0.0124
444 ANAPHYLACTIC REACTION 685 0.0124
445 EYE INFLAMMATION 118 0.0124
446 TACHYPNOEA 168 0.0123
447 ERYTHEMA 2538 0.0123
448 ADVERSE DRUG REACTION 1106 0.0123
449 ELECTROLYTE IMBALANCE 143 0.0123
450 PERIPHERAL COLDNESS 169 0.0123
451 DERMATITIS CONTACT 140 0.0123
452 LIGAMENT SPRAIN 121 0.0122
453 ACUTE RESPIRATORY FAILURE 235 0.0122
454 PAIN 7495 0.0122
455 VASCULITIS 142 0.0122
456 CELLULITIS 612 0.0121
457 BOWEL MOVEMENT IRREGULARITY 93 0.0121
458 FATIGUE 9448 0.0121
459 IRON DEFICIENCY ANAEMIA 112 0.0121
460 INSOMNIA 3223 0.0121
461 PHARYNGITIS 150 0.0121
462 POLYURIA 99 0.0121
463 DERMATITIS ALLERGIC 152 0.0121
464 SEASONAL ALLERGY 171 0.0121
465 TOOTH FRACTURE 133 0.0121
466 WHITE BLOOD CELL COUNT INCREASED 462 0.0120
467 GENERALISED OEDEMA 149 0.0120
468 PANCREATITIS 636 0.0120
469 HYPOTHYROIDISM 383 0.0120
470 DIVERTICULUM 85 0.0119
471 TENDONITIS 185 0.0119
472 PULMONARY HAEMORRHAGE 93 0.0119
473 HYDRONEPHROSIS 89 0.0119
474 ASPHYXIA 97 0.0119
475 CYTOMEGALOVIRUS INFECTION 197 0.0118
476 ENCEPHALOPATHY 291 0.0118
477 MYOPATHY 102 0.0118
478 RASH PUSTULAR 86 0.0118
479 MALAISE 5163 0.0118
480 HYPOXIA 414 0.0117
481 SWOLLEN TONGUE 366 0.0117
482 PULMONARY MASS 174 0.0117
483 SCAB 133 0.0116
484 HAEMATOCRIT DECREASED 231 0.0116
485 ASCITES 342 0.0116
486 BRONCHOSPASM 166 0.0116
487 MULTI-ORGAN FAILURE 201 0.0116
488 SINUS TACHYCARDIA 165 0.0116
489 HEART RATE INCREASED 1150 0.0116
490 SKIN REACTION 163 0.0116
491 INCONTINENCE 122 0.0115
492 PYELONEPHRITIS 100 0.0115
493 PSORIASIS 1505 0.0115
494 COAGULOPATHY 192 0.0115
495 BLOOD MAGNESIUM DECREASED 99 0.0115
496 NEUROTOXICITY 201 0.0115
497 NASAL CONGESTION 674 0.0115
498 VOMITING 5389 0.0115
499 RESPIRATORY TRACT INFECTION 297 0.0114
500 DISSEMINATED INTRAVASCULAR COAGULATION 160 0.0114
501 POLYNEUROPATHY 136 0.0113
502 ARTHROPOD BITE 84 0.0113
503 SKIN EXFOLIATION 956 0.0113
504 MUSCULOSKELETAL CHEST PAIN 175 0.0113
505 DEPRESSION 2572 0.0113
506 BLOOD SODIUM DECREASED 213 0.0113
507 RESPIRATORY FAILURE 824 0.0113
508 CYTOKINE RELEASE SYNDROME 226 0.0113
509 MUSCLE SPASMS 2065 0.0112
510 FLUID RETENTION 570 0.0112
511 EMPHYSEMA 113 0.0112
512 FOOT FRACTURE 212 0.0112
513 ADVERSE EVENT 1026 0.0111
514 DYSPNOEA 6278 0.0111
515 INTESTINAL OBSTRUCTION 418 0.0111
516 THROMBOTIC MICROANGIOPATHY 108 0.0111
517 VITAMIN D DEFICIENCY 108 0.0111
518 ASTHENIA 4152 0.0110
519 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 91 0.0110
520 NEPHROLITHIASIS 503 0.0110
521 CHILLS 1285 0.0110
522 LYMPHOPENIA 155 0.0109
523 CIRCULATORY COLLAPSE 186 0.0109
524 BACK PAIN 2535 0.0109
525 NODULE 142 0.0109
526 DYSPNOEA EXERTIONAL 409 0.0108
527 CONJUNCTIVITIS 201 0.0108
528 RESPIRATORY TRACT CONGESTION 172 0.0108
529 SKIN HAEMORRHAGE 160 0.0108
530 KIDNEY INFECTION 211 0.0107
531 CYANOSIS 169 0.0107
532 GROIN PAIN 94 0.0107
533 ANKYLOSING SPONDYLITIS 141 0.0107
534 SENSORY LOSS 86 0.0107
535 RESPIRATORY SYNCYTIAL VIRUS INFECTION 93 0.0107
536 PNEUMONIA BACTERIAL 98 0.0107
537 THROAT IRRITATION 478 0.0106
538 URINE OUTPUT DECREASED 93 0.0106
539 OROPHARYNGEAL DISCOMFORT 96 0.0106
540 ANKLE FRACTURE 164 0.0106
541 CHEST DISCOMFORT 1084 0.0106
542 CARPAL TUNNEL SYNDROME 148 0.0106
543 HEADACHE 6619 0.0105
544 INFLUENZA 1176 0.0105
545 GASTROINTESTINAL PAIN 116 0.0105
546 DEVICE RELATED INFECTION 162 0.0105
547 SPINAL COMPRESSION FRACTURE 87 0.0105
548 PANCYTOPENIA 587 0.0105
549 BLOOD PRESSURE DECREASED 695 0.0104
550 OESOPHAGITIS 113 0.0103
551 GAMMA-GLUTAMYLTRANSFERASE INCREASED 229 0.0103
552 ANAPHYLACTIC SHOCK 266 0.0103
553 TOOTHACHE 186 0.0103
554 RASH MACULAR 359 0.0103
555 HAEMOPTYSIS 286 0.0102
556 INTESTINAL PERFORATION 115 0.0102
557 RIB FRACTURE 210 0.0102
558 HYPERCALCAEMIA 126 0.0102
559 CARDIOMEGALY 125 0.0102
560 THERAPEUTIC RESPONSE DECREASED 616 0.0101
561 EJECTION FRACTION DECREASED 157 0.0101
562 NERVE INJURY 112 0.0101
563 LOCALISED INFECTION 243 0.0100
564 PLEURAL EFFUSION 611 0.0100
565 DIARRHOEA 6464 0.0100
566 DYSSTASIA 292 0.0100
567 PULMONARY EMBOLISM 950 0.0100
568 LYMPHADENOPATHY 353 0.0100
569 ERYTHEMA MULTIFORME 93 0.0100
570 NEUTROPHIL COUNT INCREASED 102 0.0100
571 SPINAL DISORDER 94 0.0099
572 HYPOTENSION 1987 0.0099
573 TRANSAMINASES INCREASED 220 0.0099
574 HERPES ZOSTER 565 0.0098
575 GASTROENTERITIS VIRAL 177 0.0098
576 HEPATIC STEATOSIS 182 0.0098
577 PROCEDURAL PAIN 271 0.0098
578 RASH MACULO-PAPULAR 217 0.0097
579 HYPOGLYCAEMIA 473 0.0097
580 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 100 0.0097
581 GASTRITIS 256 0.0097
582 INTERVERTEBRAL DISC DEGENERATION 90 0.0097
583 THROAT TIGHTNESS 263 0.0097
584 COUGH 2724 0.0097
585 HYPOTHERMIA 98 0.0097
586 COVID-19 1698 0.0097
587 ROTATOR CUFF SYNDROME 124 0.0096
588 EYE INFECTION 109 0.0096
589 HYPOKINESIA 140 0.0096
590 PULMONARY CONGESTION 127 0.0096
591 URINARY TRACT INFECTION 1639 0.0096
592 THYROID DISORDER 148 0.0096
593 LYMPHOCYTE COUNT DECREASED 169 0.0096
594 LEUKOPENIA 477 0.0095
595 LIMB DISCOMFORT 295 0.0095
596 HEPATOCELLULAR INJURY 135 0.0095
597 SKIN ULCER 246 0.0095
598 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 522 0.0095
599 SWELLING FACE 618 0.0095
600 STEVENS-JOHNSON SYNDROME 211 0.0095
601 PNEUMONITIS 258 0.0095
602 BRAIN NEOPLASM 87 0.0095
603 TINNITUS 435 0.0095
604 MASS 132 0.0094
605 POOR QUALITY SLEEP 203 0.0094
606 VISUAL IMPAIRMENT 1164 0.0094
607 QUALITY OF LIFE DECREASED 126 0.0094
608 INJECTION SITE REACTION 644 0.0093
609 PLATELET COUNT INCREASED 122 0.0093
610 ILEUS 116 0.0093
611 HEPATIC CYTOLYSIS 119 0.0093
612 MOTOR DYSFUNCTION 95 0.0093
613 THROMBOCYTOPENIA 1041 0.0093
614 PREMATURE DELIVERY 148 0.0093
615 BONE DISORDER 169 0.0093
616 CONSTIPATION 2021 0.0093
617 EYE DISCHARGE 96 0.0092
618 DEEP VEIN THROMBOSIS 600 0.0092
619 LABORATORY TEST ABNORMAL 272 0.0092
620 EYE DISORDER 303 0.0092
621 ANAEMIA 1755 0.0092
622 HYPOCALCAEMIA 174 0.0092
623 BRAIN OEDEMA 116 0.0092
624 TENDON RUPTURE 113 0.0091
625 LIMB INJURY 248 0.0091
626 ANXIETY 2594 0.0091
627 CATARACT 541 0.0091
628 SPINAL FRACTURE 182 0.0091
629 PANCREATITIS ACUTE 204 0.0091
630 PAIN IN JAW 257 0.0091
631 NAUSEA 7177 0.0091
632 EAR DISCOMFORT 93 0.0091
633 ECONOMIC PROBLEM 137 0.0090
634 LIP SWELLING 301 0.0090
635 PHOTOPHOBIA 170 0.0090
636 PHARYNGEAL SWELLING 88 0.0090
637 DIZZINESS 4479 0.0090
638 RENAL PAIN 95 0.0090
639 FACE OEDEMA 151 0.0089
640 MUSCULOSKELETAL DISCOMFORT 154 0.0089
641 WRIST FRACTURE 107 0.0089
642 HEAD DISCOMFORT 158 0.0089
643 CHOLESTASIS 171 0.0089
644 HYPERKALAEMIA 312 0.0089
645 BODY HEIGHT DECREASED 95 0.0089
646 DIABETES MELLITUS 676 0.0089
647 ACUTE KIDNEY INJURY 1354 0.0088
648 TEMPERATURE INTOLERANCE 91 0.0088
649 HYPOTONIA 88 0.0088
650 RED BLOOD CELL COUNT DECREASED 252 0.0088
651 VERTIGO 536 0.0088
652 BURNING SENSATION 615 0.0088
653 DECREASED IMMUNE RESPONSIVENESS 86 0.0088
654 MUSCLE ATROPHY 111 0.0088
655 LEUKOCYTOSIS 158 0.0087
656 FLUSHING 887 0.0087
657 UNRESPONSIVE TO STIMULI 224 0.0087
658 ATAXIA 103 0.0087
659 STATUS EPILEPTICUS 98 0.0087
660 OSTEONECROSIS 284 0.0086
661 DYSURIA 318 0.0086
662 SKIN DISCOLOURATION 395 0.0086
663 PERICARDIAL EFFUSION 198 0.0086
664 DERMATITIS ATOPIC 451 0.0085
665 MIDDLE INSOMNIA 159 0.0085
666 DRY SKIN 1136 0.0085
667 HIATUS HERNIA 110 0.0085
668 ALANINE AMINOTRANSFERASE INCREASED 520 0.0085
669 MYOCARDITIS 97 0.0085
670 BASAL CELL CARCINOMA 132 0.0085
671 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 441 0.0084
672 DIVERTICULITIS 234 0.0084
673 INFLUENZA LIKE ILLNESS 695 0.0084
674 PETECHIAE 88 0.0084
675 NEUROPATHY PERIPHERAL 802 0.0084
676 ANGIOEDEMA 373 0.0084
677 ABDOMINAL PAIN LOWER 213 0.0084
678 TOOTH DISORDER 187 0.0084
679 BONE PAIN 492 0.0084
680 BLOOD LACTATE DEHYDROGENASE INCREASED 133 0.0084
681 HAEMATOMA 217 0.0084
682 SMALL INTESTINAL OBSTRUCTION 103 0.0084
683 DRUG INEFFECTIVE 11009 0.0083
684 LACRIMATION INCREASED 252 0.0083
685 SINUS CONGESTION 112 0.0083
686 INITIAL INSOMNIA 85 0.0083
687 SINUS DISORDER 164 0.0083
688 EYE SWELLING 308 0.0083
689 DRY THROAT 84 0.0083
690 PRODUCT USE COMPLAINT 130 0.0082
691 POST PROCEDURAL COMPLICATION 158 0.0082
692 HEPATOTOXICITY 183 0.0082
693 TRANSFUSION 86 0.0082
694 CHOLELITHIASIS 269 0.0082
695 PALPITATIONS 957 0.0082
696 URINARY INCONTINENCE 242 0.0082
697 RASH PAPULAR 183 0.0082
698 HYPOAESTHESIA ORAL 123 0.0082
699 FLATULENCE 462 0.0081
700 RESTLESS LEGS SYNDROME 148 0.0081
701 DEHYDRATION 1084 0.0081
702 PULMONARY OEDEMA 363 0.0081
703 APHONIA 113 0.0081
704 ILLNESS 832 0.0081
705 ASPARTATE AMINOTRANSFERASE INCREASED 429 0.0081
706 PHOTOSENSITIVITY REACTION 133 0.0080
707 IMMUNE SYSTEM DISORDER 106 0.0080
708 BLOOD CREATININE INCREASED 525 0.0080
709 PNEUMOTHORAX 127 0.0080
710 SNEEZING 179 0.0080
711 HYPOMAGNESAEMIA 111 0.0080
712 BLOOD UREA INCREASED 133 0.0079
713 EYE PRURITUS 266 0.0079
714 SHOCK 182 0.0079
715 MOVEMENT DISORDER 254 0.0079
716 PRESYNCOPE 192 0.0079
717 CHOLECYSTITIS 94 0.0079
718 BLOOD POTASSIUM DECREASED 237 0.0079
719 MITRAL VALVE INCOMPETENCE 89 0.0079
720 NEOPLASM 90 0.0078
721 BLOOD CALCIUM DECREASED 88 0.0078
722 EATING DISORDER 166 0.0078
723 FAECES DISCOLOURED 169 0.0078
724 CHRONIC KIDNEY DISEASE 591 0.0078
725 AGRANULOCYTOSIS 144 0.0077
726 NOCTURIA 94 0.0077
727 HAEMOGLOBIN DECREASED 795 0.0077
728 PAIN OF SKIN 208 0.0077
729 COLD SWEAT 136 0.0077
730 UNDERDOSE 563 0.0077
731 GLAUCOMA 148 0.0077
732 UPPER LIMB FRACTURE 153 0.0077
733 BLOOD URINE PRESENT 145 0.0076
734 COVID-19 PNEUMONIA 90 0.0076
735 BEDRIDDEN 100 0.0076
736 BRAIN FOG 118 0.0075
737 LETHARGY 433 0.0075
738 ORTHOSTATIC HYPOTENSION 131 0.0075
739 HYPOPHAGIA 192 0.0075
740 RENAL FAILURE 997 0.0075
741 SOMNOLENCE 1497 0.0074
742 HOT FLUSH 560 0.0074
743 ANHEDONIA 195 0.0074
744 FALL 2468 0.0074
745 DYSPHONIA 433 0.0074
746 OSTEOMYELITIS 134 0.0074
747 DYSPHAGIA 702 0.0074
748 FEEDING DISORDER 150 0.0074
749 BONE MARROW FAILURE 150 0.0074
750 SENSORY DISTURBANCE 118 0.0073
751 OCULAR HYPERAEMIA 348 0.0073
752 LIVER FUNCTION TEST ABNORMAL 213 0.0073
753 CYTOPENIA 89 0.0073
754 HEPATIC FAILURE 219 0.0073
755 METABOLIC ACIDOSIS 232 0.0072
756 THERAPY PARTIAL RESPONDER 113 0.0072
757 DIPLOPIA 188 0.0072
758 MYALGIA 1227 0.0072
759 FLUID OVERLOAD 105 0.0072
760 NERVOUS SYSTEM DISORDER 225 0.0072
761 PNEUMONIA ASPIRATION 180 0.0072
762 HYPERHIDROSIS 927 0.0072
763 NIGHTMARE 249 0.0072
764 MENTAL STATUS CHANGES 199 0.0072
765 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 184 0.0071
766 HERNIA 138 0.0071
767 DRY EYE 354 0.0071
768 GENERALISED TONIC-CLONIC SEIZURE 117 0.0071
769 ACCIDENTAL OVERDOSE 258 0.0070
770 THIRST 126 0.0070
771 INCORRECT PRODUCT ADMINISTRATION DURATION 152 0.0070
772 PREMATURE BABY 210 0.0070
773 HEMIPARESIS 118 0.0070
774 FOETAL EXPOSURE DURING PREGNANCY 564 0.0069
775 BLOOD BILIRUBIN INCREASED 187 0.0069
776 BRADYCARDIA 367 0.0069
777 EPISTAXIS 515 0.0069
778 HYPERSOMNIA 196 0.0068
779 PULMONARY HYPERTENSION 142 0.0068
780 NEUTROPENIA 925 0.0068
781 SYNCOPE 680 0.0068
782 GALLBLADDER DISORDER 121 0.0068
783 CARDIOMYOPATHY 100 0.0068
784 RASH GENERALISED 175 0.0068
785 BLOOD PRESSURE ABNORMAL 134 0.0067
786 SARS-COV-2 TEST POSITIVE 89 0.0067
787 SCAR 115 0.0067
788 SEIZURE 775 0.0067
789 DEPRESSED MOOD 354 0.0067
790 BLOOD ALKALINE PHOSPHATASE INCREASED 166 0.0067
791 DISEASE RECURRENCE 315 0.0066
792 RENAL FAILURE ACUTE 277 0.0065
793 CHOKING 127 0.0065
794 RETCHING 138 0.0065
795 LOSS OF CONSCIOUSNESS 826 0.0064
796 APHASIA 193 0.0064
797 HAEMATEMESIS 162 0.0064
798 POLLAKIURIA 266 0.0064
799 THROMBOSIS 512 0.0064
800 VENTRICULAR TACHYCARDIA 105 0.0064
801 MUSCLE TIGHTNESS 103 0.0064
802 CARDIAC ARREST 524 0.0063
803 GASTRIC ULCER 120 0.0063
804 INCREASED APPETITE 120 0.0063
805 PROTEINURIA 119 0.0063
806 MUSCULOSKELETAL DISORDER 119 0.0062
807 HUNGER 87 0.0062
808 TREATMENT NONCOMPLIANCE 341 0.0062
809 TOOTH LOSS 129 0.0062
810 PARALYSIS 89 0.0062
811 PRURITUS GENERALISED 134 0.0062
812 CORONARY ARTERY DISEASE 187 0.0062
813 EYE PAIN 347 0.0061
814 SKIN CANCER 132 0.0061
815 PLATELET COUNT DECREASED 653 0.0061
816 DISTURBANCE IN ATTENTION 330 0.0061
817 DRUG INTERACTION 970 0.0061
818 BLOOD POTASSIUM INCREASED 99 0.0061
819 BLOOD TRIGLYCERIDES INCREASED 107 0.0060
820 NEOPLASM PROGRESSION 210 0.0060
821 MUSCLE TWITCHING 139 0.0060
822 LYMPHOMA 93 0.0060
823 DYSGEUSIA 447 0.0060
824 HAEMORRHAGE INTRACRANIAL 89 0.0059
825 HEAD INJURY 188 0.0059
826 BONE DENSITY DECREASED 186 0.0059
827 EOSINOPHILIA 104 0.0059
828 DYSARTHRIA 223 0.0059
829 SPEECH DISORDER 310 0.0059
830 BALANCE DISORDER 510 0.0059
831 TREMOR 973 0.0059
832 BONE LOSS 88 0.0058
833 CHROMATURIA 132 0.0058
834 LACTIC ACIDOSIS 189 0.0058
835 ACUTE MYOCARDIAL INFARCTION 172 0.0058
836 ALTERED STATE OF CONSCIOUSNESS 126 0.0058
837 BLOOD GLUCOSE ABNORMAL 107 0.0058
838 NEUTROPHIL COUNT DECREASED 236 0.0058
839 INTERNATIONAL NORMALISED RATIO INCREASED 165 0.0058
840 ATRIAL FIBRILLATION 563 0.0058
841 ANGINA PECTORIS 165 0.0058
842 RHABDOMYOLYSIS 239 0.0057
843 HAEMORRHAGE 598 0.0057
844 DISORIENTATION 226 0.0057
845 INSURANCE ISSUE 87 0.0057
846 INTENTIONAL PRODUCT MISUSE 493 0.0056
847 VISION BLURRED 771 0.0056
848 HIP FRACTURE 180 0.0056
849 TRANSIENT ISCHAEMIC ATTACK 186 0.0055
850 RESTLESSNESS 201 0.0055
851 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 128 0.0055
852 DISEASE PROGRESSION 649 0.0055
853 URINARY RETENTION 183 0.0055
854 PERITONITIS 113 0.0055
855 CRYING 198 0.0054
856 FRACTURE 103 0.0054
857 DEAFNESS 142 0.0054
858 MELAENA 119 0.0054
859 BLINDNESS 220 0.0054
860 PRODUCT PRESCRIBING ERROR 128 0.0054
861 IRRITABILITY 323 0.0054
862 RENAL IMPAIRMENT 451 0.0054
863 NERVOUSNESS 280 0.0054
864 PRODUCT PRESCRIBING ISSUE 116 0.0053
865 PRODUCT ADMINISTRATION ERROR 107 0.0053
866 SKIN BURNING SENSATION 379 0.0053
867 LOCAL SWELLING 92 0.0053
868 DEPRESSED LEVEL OF CONSCIOUSNESS 208 0.0053
869 INJECTION SITE PRURITUS 351 0.0052
870 INCORRECT DOSE ADMINISTERED 1196 0.0052
871 HAEMATURIA 179 0.0052
872 MENTAL DISORDER 227 0.0052
873 PANIC ATTACK 190 0.0052
874 WHITE BLOOD CELL COUNT DECREASED 559 0.0052
875 INTENTIONAL DOSE OMISSION 147 0.0052
876 MOOD SWINGS 164 0.0051
877 ACNE 390 0.0051
878 OSTEONECROSIS OF JAW 127 0.0051
879 FEELING ABNORMAL 1224 0.0051
880 DIABETES MELLITUS INADEQUATE CONTROL 90 0.0051
881 DRUG ERUPTION 90 0.0051
882 AGITATION 372 0.0051
883 AGEUSIA 125 0.0050
884 ARRHYTHMIA 237 0.0050
885 HALLUCINATION, VISUAL 105 0.0050
886 CARDIOVASCULAR DISORDER 126 0.0050
887 THINKING ABNORMAL 92 0.0049
888 ISCHAEMIC STROKE 88 0.0049
889 DIABETIC KETOACIDOSIS 118 0.0049
890 DRUG RESISTANCE 126 0.0049
891 PRODUCT QUALITY ISSUE 665 0.0049
892 THERAPEUTIC RESPONSE UNEXPECTED 219 0.0049
893 ERUCTATION 94 0.0049
894 CARDIAC FAILURE 389 0.0048
895 PELVIC PAIN 87 0.0048
896 NEEDLE ISSUE 138 0.0047
897 PRODUCT DOSE OMISSION IN ERROR 134 0.0047
898 CEREBRAL HAEMORRHAGE 167 0.0047
899 HYPOACUSIS 199 0.0046
900 RESPIRATORY ARREST 127 0.0046
901 FULL BLOOD COUNT DECREASED 92 0.0046
902 MALIGNANT NEOPLASM PROGRESSION 463 0.0045
903 FEMUR FRACTURE 140 0.0045
904 GASTROINTESTINAL HAEMORRHAGE 377 0.0045
905 CARDIO-RESPIRATORY ARREST 188 0.0045
906 COGNITIVE DISORDER 209 0.0045
907 JAUNDICE 120 0.0045
908 BLOOD GLUCOSE INCREASED 838 0.0044
909 PRODUCT DOSE OMISSION ISSUE 1303 0.0044
910 GASTRIC DISORDER 152 0.0044
911 PSYCHOTIC DISORDER 130 0.0044
912 ELECTROCARDIOGRAM QT PROLONGED 158 0.0044
913 SURGERY 257 0.0044
914 MENTAL IMPAIRMENT 106 0.0044
915 SKIN IRRITATION 200 0.0044
916 BLOOD GLUCOSE DECREASED 209 0.0043
917 INJECTION SITE WARMTH 89 0.0043
918 COMA 205 0.0043
919 RENAL DISORDER 200 0.0043
920 PRODUCT AVAILABILITY ISSUE 97 0.0043
921 INJECTION SITE BRUISING 339 0.0042
922 DRUG EFFECT INCOMPLETE 153 0.0042
923 MOOD ALTERED 114 0.0042
924 HOSPITALISATION 642 0.0042
925 ABASIA 103 0.0042
926 GLYCOSYLATED HAEMOGLOBIN INCREASED 105 0.0042
927 HEPATIC FUNCTION ABNORMAL 154 0.0041
928 INJECTION SITE SWELLING 309 0.0040
929 VISUAL ACUITY REDUCED 133 0.0040
930 EYE IRRITATION 230 0.0040
931 INJECTION SITE ERYTHEMA 493 0.0040
932 DRUG EFFECT DECREASED 214 0.0040
933 CEREBROVASCULAR ACCIDENT 672 0.0040
934 MULTIPLE SCLEROSIS 189 0.0039
935 INTERSTITIAL LUNG DISEASE 190 0.0039
936 DEMENTIA 109 0.0039
937 FEAR 104 0.0039
938 CONVULSION 218 0.0038
939 WITHDRAWAL SYNDROME 160 0.0038
940 EMOTIONAL DISORDER 117 0.0038
941 INJECTION SITE RASH 116 0.0038
942 DYSKINESIA 153 0.0038
943 INJECTION SITE URTICARIA 92 0.0037
944 HALLUCINATION 282 0.0037
945 MULTIPLE SCLEROSIS RELAPSE 256 0.0037
946 AGGRESSION 186 0.0037
947 CARDIAC DISORDER 344 0.0037
948 NEOPLASM MALIGNANT 243 0.0036
949 PLASMA CELL MYELOMA 141 0.0036
950 BLOOD CREATINE PHOSPHOKINASE INCREASED 104 0.0036
951 INJECTION SITE PAIN 1090 0.0035
952 CARDIAC FAILURE CONGESTIVE 284 0.0035
953 EXPIRED PRODUCT ADMINISTERED 117 0.0035
954 RENAL INJURY 104 0.0035
955 SUICIDAL IDEATION 316 0.0034
956 PRODUCT SUBSTITUTION ISSUE 198 0.0034
957 INJECTION SITE MASS 127 0.0034
958 EMOTIONAL DISTRESS 413 0.0034
959 ABORTION SPONTANEOUS 133 0.0033
960 APPLICATION SITE ERYTHEMA 86 0.0033
961 UNEVALUABLE EVENT 248 0.0033
962 DEVICE DISLOCATION 139 0.0032
963 OVERDOSE 664 0.0031
964 ABNORMAL BEHAVIOUR 121 0.0031
965 DEVICE LEAKAGE 128 0.0029
966 MYOCARDIAL INFARCTION 510 0.0029
967 INJECTION SITE HAEMORRHAGE 233 0.0029
968 ANGER 97 0.0029
969 DEVICE BREAKAGE 115 0.0028
970 THERAPY INTERRUPTED 200 0.0028
971 PRODUCT DOSE OMISSION 177 0.0027
972 VAGINAL HAEMORRHAGE 117 0.0027
973 DRUG DOSE OMISSION BY DEVICE 209 0.0027
974 TOXICITY TO VARIOUS AGENTS 433 0.0026
975 DEVICE ISSUE 229 0.0026
976 LUNG NEOPLASM MALIGNANT 104 0.0025
977 DEVICE MALFUNCTION 172 0.0024
978 NO ADVERSE EVENT 442 0.0024
979 DEATH 1983 0.0023
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 106 0.0023
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 157 0.0022
982 THERAPY CESSATION 110 0.0021
983 DRUG DOSE OMISSION 351 0.0021
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 396 0.0020
985 SUICIDE ATTEMPT 110 0.0018
986 DRUG DEPENDENCE 291 0.0018
987 INTENTIONAL OVERDOSE 91 0.0014
988 ACCIDENTAL EXPOSURE TO PRODUCT 145 0.0014
989 BREAST CANCER 130 0.0014
990 DRUG WITHDRAWAL SYNDROME 98 0.0011
991 PRODUCT STORAGE ERROR 89 0.0010